Actively Recruiting
Kinesiotaping in Trauma
Led by Onze Lieve Vrouwe Gasthuis · Updated on 2025-05-31
387
Participants Needed
1
Research Sites
159 weeks
Total Duration
On this page
Sponsors
O
Onze Lieve Vrouwe Gasthuis
Lead Sponsor
O
OLVG
Collaborating Sponsor
AI-Summary
What this Trial Is About
Rationale: Patients with acute traumatic injury to the shoulder or chest wall in de Emergency Department (ED) usually have intense pain. The patient normally is treated with oral analgesics as standard care and in shoulder injury with a sling. Pain of the shoulder or chest wall increases with movement of the affected arm and chest. Kinesiotaping is offered regularly as an additional pain treatment, but there is no hard evidence about its effectiveness. A randomized pilot study in OLVG (Bakker 2022) showed the pain decreasing more when using kinesiotaping comparing to no tape. However, a placebo-effect could not be ruled out and the pilot data need confirmation in a large cohort of patients to study the effectiveness of additional treatment with kinesiotaping in terms of pain, comfort and patient satisfaction.
CONDITIONS
Official Title
Kinesiotaping in Trauma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Injury occurred less than 24 hours ago
- Single injury to shoulder or chest wall including rib fracture
- Disruption of the acromioclavicular (AC) joint Tossy type 1 or 2
- Not or hardly displaced fracture of the clavicle
- Not or hardly displaced fracture of the proximal humerus
You will not qualify if you...
- Younger than 18 years
- Incapacitated persons
- Refusal to participate
- Need for intubation
- Decreased consciousness
- Hemodynamic instability
- Three or more rib fractures
- Rib fractures of ribs 1 to 3
- Indication for surgery
- Hospitalization required
- Presence of haemo- or pneumothorax requiring chest drain
- Known allergy to adhesive tape
- Very thin or loose skin on the affected area
- Skin infection, irritation, or open wound on the affected area
- Unable to speak Dutch or English
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mireille Bakker
Amsterdam, Netherlands, 1090 HM
Actively Recruiting
Research Team
M
Mireille Bakker, MSc
CONTACT
M
Maro Sandel, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here